The pharmaceutical company announced that it will increase its patient assistance program in hopes of quelling a growing backlash over its drug pricing.
Short-seller Andrew Left says Mallinckrodt has long been gaming the system on its Acthar Gel drug.
An Amgen drug to treat secondary hyperparathyroidism was rejected by U.S. regulators Wednesday but the biotech company offered no public explanation for why the drug's marketing application was denied.
Clinton hammers a whole sector by criticizing an increase in Epipens.
Shares of Gilead Sciences were lower Wednesday after Leerink cut its price target on the shares.
Shares of the world's second largest generic pharma company fell nearly 5% after U.S. politicians target company for price gouging.
Pfizer is making another acquisition.
The acquisition of Medivation gives the pharma giant a top-selling oncology drug and an immediate profit boost.
Pescara Del Tronto was one of the hardest hit towns in Central Italy as an earthquake rattled the country overnight.